Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer
Julia M. Houthuijzen, Roebi de Bruijn, Eline van der Burg, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 145
The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics
Jai Prakash, Yuval Shaked
Cancer Discovery (2024) Vol. 14, Iss. 8, pp. 1375-1388
Open Access | Times Cited: 36
Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
Hugo Croizer, Rana Mhaidly, Yann Kieffer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Tianchen Guo, Junfen Xu
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1095-1116
Open Access | Times Cited: 27
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Zhipeng Cao, Sadia Quazi, Sakshi Arora, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 6
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy
Zhongsong Zhang, Rong Wang, Long Chen
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 483-503
Open Access | Times Cited: 3
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Zhongsong Zhang, Long Chen
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity
Vincenzo Salemme, Giorgia Centonze, Lidia Avalle, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 40
The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer
Jian Zheng, Hua Hao
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 15
Mapping the tumor stress network reveals dynamic shifts in the stromal oxidative stress response
Chen Lior, Debra Barki, Coral Halperin, et al.
Cell Reports (2024) Vol. 43, Iss. 5, pp. 114236-114236
Open Access | Times Cited: 11
DPP4, a potential tumor biomarker, and tumor therapeutic target: review
Lu Sun, Yuhui Ma, Chenchen Geng, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
The role of cancer-associated fibroblasts in breast cancer metastasis
Yi Li, Changyuan Wang, Ting Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 19
Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer
Mikkel Morsing, Jonas Sjölund, Jiyoung Kim, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 6
FTO elicits tumor neovascularization in cancer-associated fibroblasts through eliminating m6A modifications of multiple pro-angiogenic factors
Qili Liao, Hanhan Shi, Jie Yang, et al.
Cancer Letters (2024) Vol. 592, pp. 216911-216911
Closed Access | Times Cited: 6
Cancer‑associated fibroblasts: a pivotal regulator of tumor microenvironment in the context of radiotherapy
Linhui Zheng, Wenqi Cai, Ke Yuan, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Fibroblast hierarchy dynamics during mammary gland morphogenesis and tumorigenesis
Rosa Pascual, Jinming Cheng, A. Smet, et al.
The EMBO Journal (2025)
Open Access
Differential induction of T-cell tolerance by tumour fibroblast subsets
Zoe M.X. Chua, Fitsumbhran Tajebe, Mohammed H. Abuwarwar, et al.
Current Opinion in Immunology (2024) Vol. 86, pp. 102410-102410
Closed Access | Times Cited: 4
Cancer-associated fibroblasts mediate resistance to anti-EGFR therapies in cancer
Shuang Dai, Yingtong Liu, Zheran Liu, et al.
Pharmacological Research (2024) Vol. 206, pp. 107304-107304
Open Access | Times Cited: 4
Single-Cell Multimodal Profiling Reveals a Novel CD26+ Fibroblast Subpopulation in Atherosclerosis
Alexander C. Bashore, Johana Coronel, Chenyi Xue, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Mitochondrial metabolism-related features guiding precision subtyping and prognosis in breast cancer, revealing FADS2 as a novel therapeutic target
Yakun Kang, Meng You, J. Jin, et al.
Translational Oncology (2025) Vol. 54, pp. 102330-102330
Closed Access
Cancer-associated fibroblasts in breast cancer in the single-cell era: Opportunities and challenges
Jingtong Yang, Benkai Xin, Xiaoyu Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189291-189291
Closed Access
The fibroinflammatory response in cancer
Zebin Xiao, Ellen Puré
Nature reviews. Cancer (2025)
Closed Access
CD105+ fibroblasts support an immunosuppressive niche in women at high risk of breast cancer initiation
Eric G. Carlson, Jennifer C. Lopez, Yukiko Yamaguchi, et al.
Research Square (Research Square) (2025)
Closed Access
Modeling Stromal Cells Inside the Tumor Microenvironment of Ovarian Cancer: In Vitro Generation of Cancer‐Associated Fibroblast‐Like Cells and Their Impact in a 3D Model
Jacopo Romoli, Paola Chiodelli, Patrizia Bonassi Signoroni, et al.
MedComm (2025) Vol. 6, Iss. 5
Open Access
Emerging treatment approaches for triple-negative breast cancer
Maurizio Capuozzo, Venere Celotto, Mariachiara Santorsola, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top